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patients with moderate use of alcohol had 23.8% lower risk of all-cause death (p<.00016)
and a 25.8% lower risk of CV-death (p<.00017) than non-users. There was no significant
difference between non-drinkers and heavy-drinkers with regard to survival following
adjustment for age and smoking status.
Conclusion: Our results demonstrate a positive and strong association between 
moderate alcohol use and survival in a cohort of patients following complicated MI.
1153-74 Physician Counseling Can Influence Health-Related 
Quality of Life
Barbara L. Lytle, Gregory J. Shook, Karen P. Alexander, Patricia A. Cowper, Daniel B. 
Mark, Elizabeth R. DeLong, Duke Clinical Research Institute, Durham, NC
Background: Secondary prevention counseling (SPC) by physicians (MDs) is a vital
component of guidelines-based care after hospitalization for coronary artery disease
(CAD). Yet, there is limited evidence of its benefits on patient (pt) well-being. Among
1298 members of two not-for-profit managed care organizations, we evaluated the rela-
tionship between reported SPC and self-rated health improvement following a CAD hos-
pitalization. Methods: All pts were surveyed approximately 9 months after a
hospitalization for unstable angina, myocardial infarction, percutaneous intervention, or
coronary artery bypass surgery. Health-status was assessed using the SF-36 Reported
Health Transition scale. Results: One quarter (28%) of all pts reported feeling “much bet-
ter” compared to the previous year. Compared to others, pts were more likely to feel
much better if they reported SPC about management of chest pain (29% vs 23%), cho-
lesterol (30% vs 20%), blood pressure (29% vs 22%), and diabetes (30% vs 25%), as
well as exercise advice (30% vs 18%), heart attack symptoms (29% vs 25%), and when
to go to the emergency room (29% vs 25%). A dramatic gradient in well-being was
observed according to respondent ratings of whether the MD was easy to understand:
strongly agree (35% much better), agree (20%), not sure (13%), disagree (8%), strongly
disagree (11%). In stepwise logistic regression, after controlling for the reason for hospi-
talization, significant predictors of feeling much better were understandable MD language
(p<0.0001), review of symptoms of a heart attack (p=.003), and advice on cholesterol
control (p=.03) and exercise (p=.03). Conclusion: Comprehensive SPC in understand-
able language has a demonstrable effect on a patient’s sense of well-being. As a compo-
nent of quality healthcare, the importance of these interactions on the overall health of
pts should not be underestimated.
1153-75 Physician Beliefs About the Treatment of 
Hyperlipidemia and Treatment to National Cholesterol 
Education Program Low-Density-Lipoprotein 
Cholesterol Goal in High-Risk Patients
Kathleen A. Foley, Ross J. Simpson, Jr., Kathy Berra, Shiva Sajjan, Leona E. Markson, 
Charles M. Alexander, Merck & Co., Inc., West Point, PA
Background: Many high-risk patients do not receive therapy that is sufficiently aggressive
to achieve LDL-C goal. This study describes the relationships between physician beliefs
and statin treatment decisions for high-risk patients.
Methods: A cross-sectional study of 108 physicians and 1,187 statin-treated patients with
a NCEP LDL-C goal <l00 mg/dL was conducted in 2002. Physicians completed a survey
prior to enrolling patients. Treatment history was collected from a chart review. Beliefs
were measured using validated scales with a 5-point scale. Patient follow-up was catego-
rized into changes that increased or decreased a patient’s chance of goal attainment.
The relationships between physician beliefs and type of follow-up change were analyzed
using multivariate GEE models to account for physician effect, controlling for patient char-
acteristics. Odds ratios (95% CI) are reported.
Results: The majority of physicians were in internal medicine (51%) or general practice
(38%). Mean patient age was 65.8 (SD 10.6) and 56% were male. Mean pre-treatment
LDL was 154.5 (SD 43.8). On average, physicians treated these patients for 3.5 years.
Although 75% of physicians agree with guidelines that close enough to goal is not good
enough, 43% of these high-risk patients were not at LDL-C goal and 35% who were not
at goal with initial therapy were either down-titrated, had no change in therapy or had an
ambiguous change. Mean follow-up LDL was 122.8 (SD 24.2) for those not at goal. 70%
of physicians did not believe treating to goal was an urgent need. Physician beliefs asso-
ciated with a decreased chance of goal attainment at follow-up included risks associated
with titrating a statin (OR:1.70; 1.13 – 2.56), getting patients within 10 or 20 points of goal
is close enough (OR: 1.83; 1.24 – 2.69) and current statin therapies are not effective for
getting patients to goal (OR: 4.76; 3.03 – 7.46).
Conclusions: While most physicians agree with current treatment guidelines, their beliefs
about statins and the urgency of treating hyperlipidemia may act as barriers to treating
patients to goal. Programs such as NCEP should incorporate information on physician
beliefs to further improve patient outcomes in clinical practice.
1153-76 Engaging Personal Physicians as Study Investigators: 
Can It Enhance Patient Enrollment in Clinical Trials?
Noelle Sherber, Neil R. Powe, Joel B. Braunstein, Johns Hopkins Medical Institutions, 
Baltimore, MD
Background: Limited enrollment in clinical trials obscures significant findings, wastes
resources, and unnecessarily exposes participating patients to harm. Evaluating ways to
improve enrollment, we asked whether patients would be more willing to participate
(WTP) in a cardiovascular drug trial if their personal rather than an unfamiliar physician
was engaged as the study investigator.
Methods: We approached 1440 randomly selected patients from 13 Maryland-based
outpatient cardiology and general medicine clinics to complete an 80-item self-adminis-
tered questionnaire. Respondents read a 1-page trial description and reported their WTP
using a 5-point Likert response scale. We then asked respondents their WTP if their per-
sonal rather than an unfamiliar physician was the study investigator. Patients rated trust
in physicians and quality of their health care experiences, to assess the importance of
these factors to explain any differences in WTP between personal and unfamiliar physi-
cian.
Results: Of 1132 patients eligible, 789 (70%) patients responded. Including only those
with a personal physician and complete data (n=666), patients were mean (sd) aged 55
(15) years, 53% female, and 33% black. Patients were “very likely/likely” to participate in
the study 56% of the time if conducted by their personal compared to only 36% if by an
unfamiliar physician (p<0.0001). After adjusting for age, race, gender, and socioeconomic
and health status, only presence of a family member or friend in health care was posi-
tively associated with “very likely/likely” WTP with unfamiliar physician (OR, 95% CI =
1.42, 0.99-2.03). If by a personal physician, however, trust in physician (1.57, 1.16-2.11,
per 1/5 unit increase), rating of health care quality (1.18, 1.06-1.31, per 1/10 unit
increase), and having a family member or friend in health care (1.57, 1.16-2.11) were
important predictors of WTP.
Conclusion: Patients are much more likely to enroll in a clinical trial if their personal phy-
sician is engaged as a study investigator. Greater enrollment through use of personal
physicians could relate to the importance of communication, trust, and familiarity with the
health system in patients’ participation decisions.
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846-1 Volume-Based Referral for Coronary Artery Bypass 
Graft Surgery and Percutaneous Coronary Intervention: 
Is the Volume Juice Worth the Squeeze?
Andrew J. Epstein, Saif S. Rathore, Harlan M. Krumholz, Kevin G.M. Volpp, University of 
Pennsylvania Wharton School of Business, Philadelphia, PA, Yale University School of 
Medicine, New Haven, CT
Background: Hospital volume minimums for coronary bypass graft (CABG) and percuta-
neous coronary intervention (PCI) have been advocated to reduce mortality. The number
of patients affected and lives saved by adopting volume minimums is unknown.
Methods: Using data from the 1998-2001 Nationwide Inpatient Sample, an administra-
tive database of discharges from a sample of US hospitals, we classified hospitals as low
volume hospitals (LVHs) if they did not meet annual procedure volume minimums recom-
mended by the Leapfrog Group (CABG 450 cases, PCI 400 cases); all other hospitals
were considered high volume (HVH). Multivariable logistic regression analyses were
used to evaluate the independent association between hospital volume and in-hospital
mortality adjusting for patient factors. Lives saved by the adoption of hospital volume min-
imums were estimated by predicting mortality assuming all LVH patients were instead
treated at HVHs.
Results: Patients at LVHs had a higher crude in-hospital mortality rate for CABG (3.85%
vs. 3.51% HVH, P=0.015) and PCI (1.96% vs. 1.43%, P<0.001). Odds of in-hospital mor-
tality remained higher for patients treated at LVHs for CABG (OR 1.16, 95% CI 1.09-1.23)
and PCI (OR 1.12, 95% CI 1.05-1.20) after multivariable adjustment. Treating all US
patients at HVHs would require moving 143,687 CABG cases and 87,661 PCI cases
from LVHs each year. Based on the association of volume and mortality and assuming
that the mortality risk for transferred patients would be comparable to that of patients cur-
rently treated at HVHs, moving LVH cases to HVHs would save an estimated 625 lives
annually among CABG patients and 109 lives annually among PCI patients. Averting a
single volume-associated death for CABG patients would require treating 230 patients at
HVHs instead of LVHs, while 805 PCI patients would have to be treated at HVHs instead
of LVHs to avert one volume-associated death annually.
Conclusion: Applying hospital volume-based minimums for CABG and PCI in the US
would require moving 231,348 cases annually from LVHs to HVHs and, in the most opti-
mistic case, result in 1,035 fewer deaths. The feasibility and costs of such a volume-
based referral policy are unknown.
Alcohol use at baseline and survival compared to non-users (HR=hazard ratio)
Alcohol use (drinks/week) 1-7 >7
All-cause mortality, unadjusted
(n=946)
HR 0.58 (0.51-0.66; 
p<.00001)
HR 0.63 (0.50-0.80; 
p<.00015)
All-cause mortality, adjusted for 
age and smoking status
HR 0.76 (0.66-0.88; 
p<.00016)
HR 1.01 (0.79-1.29; p<.93)
CV-mortality, unadjusted
(n=783)
HR 0.56 (0.48-0.65; 
p<.00001)
HR 0.60 (0.46-0.78; 
p<.00015)
CV-mortality, adjusted for age 
and smoking status
HR 0.74 (0.64-0.87; 
p<.00017)
HR 0.97 (0.74-1.28; p<.85)
